Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery.

作者信息

Zencirkiran Agus Hicaz, Uygur Begum, Guler Arda, Demirci Gokhan, Kalkan Ali K, Yildiz Mustafa

机构信息

Department of Cardiology, Saglik Bilimleri University Mehmet Akif Ersoy Cardiovascular and Thoracic Surgery Educational and Research Hospital, Istanbul, Turkey.

出版信息

Blood Coagul Fibrinolysis. 2018 Sep;29(6):559-561. doi: 10.1097/MBC.0000000000000754.

DOI:10.1097/MBC.0000000000000754

PMID:29985194

Abstract

: Pulmonary embolism is a life-threatening disease which represents with high mortality and morbidity. Systemic fibrinolysis is the first-line recommended therapy in hemodynamically instable patients with massive pulmonary embolism. Systemic fibrinolytic treatment remains controversial for pulmonary embolism after surgery due to high risk of hemorrhage. Herein, we report a 49-year-old man with massive pulmonary embolism after meniscus surgery, successfully treated with low-dose prolonged infusion of tissue type plasminogen activator.

摘要